Osong Public Health and Research Perspectives10.1016/j.phrp.2013.11.001201346291-292What is Next for HIV/AIDS in Korea?Hae-Wol Cho, Chaeshin Chu,
Nature10.1038/d41586-019-03738-32019Daily briefing: Authors of five seminal HIV/AIDS papers tell what happened nextFlora Graham,,
Current HIV/AIDS Reports10.1007/s11904-013-0157-92013102142-151Use of Antiretrovirals for HIV Prevention: What Do We Know and What Don’t We Know?Jared M. Baeten, Robert Grant,,
Current HIV/AIDS Reports10.1007/s11904-014-0237-52014114496-504Treatment as Prevention—Where Next?Mark Hull, Joep Lange, Julio S. G. Montaner,,
Current HIV/AIDS Reports10.1007/s11904-008-0004-620085120-26Regulatory T cells in HIV infection: Who’s suppressing what?Nabila Seddiki, Anthony D. Kelleher,,
Tropical Medicine & International Health10.1111/j.1365-3156.2010.02566.x2010158975-980What is new in HIV/AIDS research in developing countries?Anatoli Kamali,
The AIDS Pandemic10.1016/b978-012465271-2/50007-8200590-109The Public Health Response to HIV/AIDS: What Have We Learned?Mitchell H Katz,
Learning from HIV and AIDS10.1017/cbo9780511614026.0062003111-147What have clinicians learnt from working with HIV/AIDS? A medical perspective from LondonChris G. A. Wood, George T. H. Ellison
Current HIV/AIDS Reports10.1007/s11904-012-0112-1201292179-185Protease Inhibitor Monotherapy: What Is Its Role?Miriam Estébanez, Jose R. Arribas,,
Current HIV/AIDS Reports10.1007/s11904-021-00545-22021183211-220Immunologic Control of HIV-1: What Have We Learned and Can We Induce It?Daniel C. Rogan, Mark Connors,,